Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Shares Issued
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Treasury Shares
Common Stock - Number of Shares, Treasury Shares
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect Period of Adoption Adjustment
Retained Earnings
Cumulative Effect Period of Adoption Adjusted Balance
Balance at beginning of period at Dec. 31, 2018 $ 552,568     $ 33   $ (108,637)   $ 569,712   $ (6,079)   $ 97,539    
Beginning balance, shares issued (shares) at Dec. 31, 2018       33,202,369                    
Beginning balance, treasury stock (shares) at Dec. 31, 2018           (2,273,932)                
Beginning balance, shares outstanding (shares) at Dec. 31, 2018       30,928,437                    
Stock options exercised 2,979             2,979            
Stock options exercised (shares)       181,900                    
Restricted stock awards, net of forfeitures (shares)       87,433                    
Share-based compensation expense 2,266             2,266            
Restricted stock surrendered due to employee tax liability (461)         $ (461)                
Restricted stock surrendered due to employee tax liability (shares)       (23,889)   (23,889)                
Cash dividends declared (common stock, $0.24/share, $0.08/share, $0.72/share, $0.44/share) (22,316)                     (22,316)    
Net income 29,704                     29,704    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 9,787                 9,787        
Balance at end of period at Sep. 30, 2019 574,527     $ 33   $ (109,098)   574,957   3,708   104,927    
Ending balance, shares issued (shares) at Sep. 30, 2019       33,471,702                    
Ending balance, treasury stock (shares) at Sep. 30, 2019           (2,297,821)                
Ending balance, shares outstanding (shares) at Sep. 30, 2019       31,173,881                    
Balance at beginning of period at Jun. 30, 2019 564,457     $ 33   $ (109,077)   571,105   2,375   100,021    
Beginning balance, shares issued (shares) at Jun. 30, 2019       33,271,832                    
Beginning balance, treasury stock (shares) at Jun. 30, 2019           (2,296,669)                
Beginning balance, shares outstanding (shares) at Jun. 30, 2019       30,975,163                    
Stock options exercised 2,957             2,957            
Stock options exercised (shares)       180,000                    
Restricted stock awards, net of forfeitures (shares)       19,870                    
Share-based compensation expense 895             895            
Restricted stock surrendered due to employee tax liability (21)         $ (21)                
Restricted stock surrendered due to employee tax liability (shares)       (1,152)   (1,152)                
Cash dividends declared (common stock, $0.24/share, $0.08/share, $0.72/share, $0.44/share) (7,470)                     (7,470)    
Net income 12,376                     12,376    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 1,333                 1,333        
Balance at end of period at Sep. 30, 2019 574,527     $ 33   $ (109,098)   574,957   3,708   104,927    
Ending balance, shares issued (shares) at Sep. 30, 2019       33,471,702                    
Ending balance, treasury stock (shares) at Sep. 30, 2019           (2,297,821)                
Ending balance, shares outstanding (shares) at Sep. 30, 2019       31,173,881                    
Balance at beginning of period at Dec. 31, 2019 $ 563,267 $ (12,167)   $ 33   $ (116,515)   $ 575,816   $ 3,382   $ 100,551 $ (12,167)  
Beginning balance, shares issued (shares) at Dec. 31, 2019       33,475,402 33,475,402                  
Beginning balance, treasury stock (shares) at Dec. 31, 2019 (2,675,778)         (2,675,778) (2,675,778)              
Beginning balance, shares outstanding (shares) at Dec. 31, 2019       30,799,624 30,799,624                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member     us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member    
Adjusted balance at Dec. 31, 2019     $ 551,101   $ 33   $ (116,515)   $ 575,816   $ 3,382     $ 88,385
Restricted stock awards, net of forfeitures (shares)       85,581                    
Share-based compensation expense $ 1,911             $ 1,911            
Restricted stock surrendered due to employee tax liability (317)         $ (317)                
Restricted stock surrendered due to employee tax liability (shares)       (30,214)   (30,214)                
Repurchase of common stock (2,196)         $ (2,196)                
Repurchase of common stock (shares)       (135,400)   (135,400)                
Cash dividends declared (common stock, $0.24/share, $0.08/share, $0.72/share, $0.44/share) (13,504)                     $ (13,504)    
Net income 27,870                     27,870    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (1,661)                 $ (1,661)        
Balance at end of period at Sep. 30, 2020 $ 563,203     $ 33   $ (119,029)   577,727   1,721   102,751    
Ending balance, shares issued (shares) at Sep. 30, 2020       33,560,983                    
Ending balance, treasury stock (shares) at Sep. 30, 2020 (2,841,392)         (2,841,392)                
Ending balance, shares outstanding (shares) at Sep. 30, 2020       30,719,591                    
Balance at beginning of period at Jun. 30, 2020 $ 547,436     $ 33   $ (119,002)   577,211   335   88,859    
Beginning balance, shares issued (shares) at Jun. 30, 2020       33,495,913                    
Beginning balance, treasury stock (shares) at Jun. 30, 2020           (2,838,284)                
Beginning balance, shares outstanding (shares) at Jun. 30, 2020       30,657,629                    
Restricted stock awards, net of forfeitures (shares)       65,070                    
Share-based compensation expense 516             516            
Restricted stock surrendered due to employee tax liability (27)         $ (27)                
Restricted stock surrendered due to employee tax liability (shares)       (3,108)   (3,108)                
Cash dividends declared (common stock, $0.24/share, $0.08/share, $0.72/share, $0.44/share) (2,452)                     (2,452)    
Net income 16,344                     16,344    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 1,386                 1,386        
Balance at end of period at Sep. 30, 2020 $ 563,203     $ 33   $ (119,029)   $ 577,727   $ 1,721   $ 102,751    
Ending balance, shares issued (shares) at Sep. 30, 2020       33,560,983                    
Ending balance, treasury stock (shares) at Sep. 30, 2020 (2,841,392)         (2,841,392)                
Ending balance, shares outstanding (shares) at Sep. 30, 2020       30,719,591